Malaysian Genomics Resource (0155) — Cash Flow Reinvestment Rate
Malaysian Genomics Resource (0155) has a Cash Flow Reinvestment Rate of 0.08x as of December 2025, reinvesting RM72.00K (capex RM72.00K ) from operating cash flow of RM960.00K. Explore Malaysian Genomics Resource capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Malaysian Genomics Resource Cash Flow Reinvestment Rate (2015–2022)
Historical reinvestment intensity for Malaysian Genomics Resource across 5 annual periods. Also explore total assets of Malaysian Genomics Resource for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Malaysian Genomics Resource (2015–2022)
Year-by-year capital reinvestment analysis for Malaysian Genomics Resource. For live market cap and broader valuation context, see Malaysian Genomics Resource market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (MYR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 66.19x | RM3.77 Million | RM56.92K | RM1.33 Million | ▲ +2350.0% |
| 2020 | 2.70x | RM31.52 Million | RM11.67 Million | RM351.18K | ▼ -15.3% |
| 2017 | 3.19x | RM11.72 Million | RM3.67 Million | RM143.49K | ▲ +4571.4% |
| 2016 | 0.07x | RM251.52K | RM3.68 Million | RM181.42K | ▼ -91.5% |
| 2015 | 0.80x | RM318.34K | RM395.83K | RM318.34K | — |